The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Rapid Growth in Recent Years

• Current Market Expansion: The cell therapy technologies market has grown significantly, increasing from $4.29 billion in 2023 to $4.97 billion in 2024, at a compound annual growth rate (CAGR) of 15.8%.
• Key Growth Drivers:
  • Strong economic growth in emerging markets.
  • Increased healthcare expenditure.
  • Government investments in cell-based research.
  • Growing demand for personalized medicine.

Promising Future Prospects

• Continued Growth Forecast: The market is expected to reach $8.62 billion by 2028, with a CAGR of 14.8%.
• Future Growth Factors:
  • Rising aging population.
  • Increasing prevalence of cancer.
  • Higher R&D spending in the pharmaceutical sector.
  • Advancements in cell therapies.
• Emerging Trends:
  • Development of innovative products and technologies.
  • Investment in manufacturing facilities.
  • Strategic partnerships and collaborations.

Read More On The Cell Therapy Technologies Market Report 2024 – https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Government Investments Fuel Market Growth

• Key Role of Government Funding: Increasing investments by governments in cell-based research are a significant growth driver. These investments aim to develop therapies for diseases like cancer and cardiovascular disease.
• Example of Investment: In May 2022, the California Institute for Regenerative Medicine (CIRM) invested over $11 million in a clinical trial for a cell therapy to treat throat cancer, potentially saving patients from the side effects of radiotherapy.

Innovations in Cell Therapy Technologies
Leading Companies and Their Innovations

• Invetech’s Korus System: In June 2022, Invetech launched Korus, a closed system for autologous cell therapies. It uses gentle elutriation and counterflow centrifugation to supply cleaner cell populations, improving cell therapy production processes like CAR-T and IPSC-derived therapies.
  • Benefits:
    • Higher recovery and purity of target cells.
    • Improved performance of cell therapy processes.
    • Expedited clinical development and scale-up of products.

Strategic Acquisitions

• Evotec’s Acquisition of Rigenerand Srl: In July 2022, Evotec acquired Rigenerand Srl, an Italian cell technology firm specializing in cGMP manufacturing of cell therapies. This acquisition strengthens Evotec’s position in the cell therapy market.
  • Impact:
    • Enhanced manufacturing capabilities.
    • Expansion of Evotec’s cell therapy portfolio.

Market Segmentation

• By Product: Consumables, Equipment, Systems, and Software.
• By Cell Type: T-cells, Stem Cells, Other Cells.
• By Process: Cell Processing, Cell Preservation, Distribution and Handling, Process Monitoring and Quality Control.
• By End User: Life Science Companies, Research Institutes, and Cell Banks.

Regional Insights

• North America’s Leadership: In 2023, North America was the largest region in the cell therapy technologies market, driven by robust research activities and healthcare infrastructure.
• Asia-Pacific’s Rapid Growth: The Asia-Pacific region is expected to record the fastest growth over the forecast period, fueled by increasing investments in healthcare and biotechnology sectors.

Conclusion
The cell therapy technologies market is experiencing rapid growth, driven by government investments, innovations in technology, and strategic acquisitions. With the market projected to continue its upward trajectory, stakeholders in the healthcare and biotechnology sectors are poised to benefit from the advancements and increased adoption of cell therapies. As major companies continue to develop innovative products and expand their capabilities, the future of cell therapy technologies looks promising, with significant potential to improve patient outcomes and advance medical research.

Request for A Sample Of The Global Cell Therapy Technologies Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=4122&type=smp